These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 19412949

  • 1. Pain intensity on and off levodopa in patients with Parkinson's disease.
    Nebe A, Ebersbach G.
    Mov Disord; 2009 Jun 15; 24(8):1233-7. PubMed ID: 19412949
    [Abstract] [Full Text] [Related]

  • 2. Response to heat pain stimulation in idiopathic Parkinson's disease.
    Nandhagopal R, Troiano AR, Mak E, Schulzer M, Bushnell MC, Stoessl AJ.
    Pain Med; 2010 Jun 15; 11(6):834-40. PubMed ID: 20624238
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T, Fox K, Mancini F, Canesi M, Odin P, Chaudhuri KR.
    Mov Disord; 2009 Jul 30; 24(10):1468-74. PubMed ID: 19425079
    [Abstract] [Full Text] [Related]

  • 5. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.
    Stacy M, Bowron A, Guttman M, Hauser R, Hughes K, Larsen JP, LeWitt P, Oertel W, Quinn N, Sethi K, Stocchi F.
    Mov Disord; 2005 Jun 30; 20(6):726-33. PubMed ID: 15719426
    [Abstract] [Full Text] [Related]

  • 6. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
    Brefel-Courbon C, Payoux P, Thalamas C, Ory F, Quelven I, Chollet F, Montastruc JL, Rascol O.
    Mov Disord; 2005 Dec 30; 20(12):1557-63. PubMed ID: 16078219
    [Abstract] [Full Text] [Related]

  • 7. Effects of dopaminergic treatment on bladder function in Parkinson's disease.
    Winge K, Werdelin LM, Nielsen KK, Stimpel H.
    Neurourol Urodyn; 2004 Dec 30; 23(7):689-96. PubMed ID: 15382192
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
    O'Sullivan JD, Said CM, Dillon LC, Hoffman M, Hughes AJ.
    Mov Disord; 1998 Nov 30; 13(6):900-6. PubMed ID: 9827613
    [Abstract] [Full Text] [Related]

  • 10. Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.
    Marras C, Lang A, Krahn M, Tomlinson G, Naglie G, Parkinson Study Group.
    Mov Disord; 2004 Jan 30; 19(1):22-8. PubMed ID: 14743356
    [Abstract] [Full Text] [Related]

  • 11. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH, Klasser M, Reichmann H.
    Fortschr Neurol Psychiatr; 2008 Oct 30; 76(10):594-9. PubMed ID: 18833504
    [Abstract] [Full Text] [Related]

  • 12. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J, Möller B, Witt K, Pinsker MO, Deuschl G, Volkmann J.
    Mov Disord; 2009 Jun 15; 24(8):1206-10. PubMed ID: 19412937
    [Abstract] [Full Text] [Related]

  • 13. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort InvestigatorsDepartment of Neurology, University of Rochester, 1351 Mt Hope Ave, Ste 220, Rochester, NY 14620, USA. kevin.biglan@ctcc.rochester.edu.
    Arch Neurol; 2009 May 15; 66(5):563-70. PubMed ID: 19433655
    [Abstract] [Full Text] [Related]

  • 14. Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease?
    Lim SY, Farrell MJ, Gibson SJ, Helme RD, Lang AE, Evans AH.
    Mov Disord; 2008 Sep 15; 23(12):1689-95. PubMed ID: 18709675
    [Abstract] [Full Text] [Related]

  • 15. Facilitated temporal summation of pain at spinal level in Parkinson's disease.
    Perrotta A, Sandrini G, Serrao M, Buscone S, Tassorelli C, Tinazzi M, Zangaglia R, Pacchetti C, Bartolo M, Pierelli F, Martignoni E.
    Mov Disord; 2011 Feb 15; 26(3):442-8. PubMed ID: 21462260
    [Abstract] [Full Text] [Related]

  • 16. [Study of associated clinical variables and phenomenology of hallucinations in Parkinson's].
    Cubo E, González M, Aguilar A, Quintana S.
    Neurologia; 2006 Feb 15; 21(1):12-8. PubMed ID: 16525921
    [Abstract] [Full Text] [Related]

  • 17. Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations.
    Hauser RA, Shulman LM, Trugman JM, Roberts JW, Mori A, Ballerini R, Sussman NM, Istradefylline 6002-US-013 Study Group.
    Mov Disord; 2008 Nov 15; 23(15):2177-85. PubMed ID: 18831530
    [Abstract] [Full Text] [Related]

  • 18. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
    Hauser RA, Rascol O, Korczyn AD, Jon Stoessl A, Watts RL, Poewe W, De Deyn PP, Lang AE.
    Mov Disord; 2007 Dec 15; 22(16):2409-17. PubMed ID: 17894339
    [Abstract] [Full Text] [Related]

  • 19. The relation of testosterone levels with fatigue and apathy in Parkinson's disease.
    Kenangil G, Orken DN, Ur E, Forta H, Celik M.
    Clin Neurol Neurosurg; 2009 Jun 15; 111(5):412-4. PubMed ID: 19131155
    [Abstract] [Full Text] [Related]

  • 20. Extradural motor cortex stimulation in Parkinson's disease.
    Cilia R, Landi A, Vergani F, Sganzerla E, Pezzoli G, Antonini A.
    Mov Disord; 2007 Jan 15; 22(1):111-4. PubMed ID: 17083104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.